Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Monday, 13 November 2017

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...

Sanofi    

Published: 18:00 CET 13-11-2017 /GlobeNewswire /Source: Sanofi / : SAN /ISIN: FR0000120578


Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l'Autorité des Marchés Financiers (Regulation of the French stock market authority)

 

Sanofi

a French société anonyme with a registered share capital of 2,522,417,258 €

Registered office : 54, rue La Boétie - 75008 Paris - France

Registered at the Paris Commercial and Companies Registry under number 395 030 844

 

Date

 

Total number of
issued shares

 

Number of real
voting rights
(excluding treasury shares)

Theoretical number of
voting rights
(including treasury shares)*

October 31, 2017

1,263,134,158

1,399,188,617

1,409,742,698

 

*  Pursuant to article 223-11 of the Règlement général de l'Autorité des Marchés Financiers.

 

This information is also available on the internet website of sanofi under « Regulated Information in France »: http://en.sanofi.com/investors/regulated_info_france/regulated_info_france.asp

 

Investor Relations Department
Europe Tel: + 33 1 53 77 45 45           US Tel: + 1 908 981 5560
e-mail:
IR@sanofi.com

Media Relations Department
Tel: + 33 1 53 77 46 46
 e-mail:
MR@sanofi.com

 



Press release (PDF)



This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of Nasdaq Corporate Solutions clients. Source: Sanofi, 54 rue la Boetie, PARIS 75008, FRANCE
If you would like to unsubscribe and stop receiving these e-mails click here.